Last update 14 Nov 2025

24-valent pneumococcal conjugate vaccine(Microbial Technology)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Conjugated vaccine
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
Infectious Diseases
Active Indication
invasive Streptococcus pneumoniae infection
Inactive Indication-
Originator Organization
Suzhou Ju Microbial Technology Co., Ltd
Active Organization
Suzhou Ju Microbial Technology Co., Ltd
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with 24-valent pneumococcal conjugate vaccine(Microbial Technology)
CTR20253592
/ Not yet recruitingPhase 1
评价24 价肺炎球菌结合疫苗接种2 月龄（最小6 周龄）至49 周岁健康人群后安全性与初步免疫原性的随机、双盲、阳性疫苗对照Ⅰ期临床试验
[Translation] A randomized, double-blind, positive-controlled phase I clinical trial to evaluate the safety and preliminary immunogenicity of the 24-valent pneumococcal conjugate vaccine in healthy individuals aged 2 months (minimum 6 weeks) to 49 years.
100 Clinical Results associated with 24-valent pneumococcal conjugate vaccine(Microbial Technology)
Login to view more data
100 Translational Medicine associated with 24-valent pneumococcal conjugate vaccine(Microbial Technology)
Login to view more data
100 Patents (Medical) associated with 24-valent pneumococcal conjugate vaccine(Microbial Technology)
Login to view more data
100 Deals associated with 24-valent pneumococcal conjugate vaccine(Microbial Technology)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
invasive Streptococcus pneumoniae infectionPhase 1
China
Suzhou Ju Microbial Technology Co., Ltd
11 Sep 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free